KEGG   PATHWAY: ppad04310
Entry
ppad04310                   Pathway                                
Name
Wnt signaling pathway - Panthera pardus (leopard)
Description
Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.
Class
Environmental Information Processing; Signal transduction
Pathway map
ppad04310  Wnt signaling pathway
ppad04310

Other DBs
GO: 0016055
Organism
Panthera pardus (leopard) [GN:ppad]
Gene
109248062  PORCN; protein-serine O-palmitoleoyltransferase porcupine isoform X1 [KO:K00181] [EC:2.3.1.250]
109249055  WNT1; proto-oncogene Wnt-1 [KO:K03209]
109248384  WNT2; protein Wnt-2 [KO:K00182]
109272063  WNT2B; protein Wnt-2b [KO:K00182]
109259603  protein Wnt-3a [KO:K00312]
109259748  WNT3; proto-oncogene Wnt-3 isoform X1 [KO:K00312]
109274277  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
109279118  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
109276247  WNT5B; protein Wnt-5b [KO:K00444]
109265051  WNT6; protein Wnt-6 [KO:K00445]
109265719  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
109257500  WNT7A; protein Wnt-7a [KO:K00572]
109252095  WNT8A; protein Wnt-8a [KO:K00714]
109272682  WNT8B; protein Wnt-8b [KO:K00714]
109259601  WNT9A; protein Wnt-9a isoform X1 [KO:K01064]
109259736  WNT9B; protein Wnt-9b [KO:K01064]
109265050  WNT10A; protein Wnt-10a [KO:K01357]
109249054  WNT10B; protein Wnt-10b [KO:K01357]
109267221  WNT11; protein Wnt-11 [KO:K01384]
109268901  WNT16; protein Wnt-16 [KO:K01558]
109247092  CER1; cerberus [KO:K01645]
109276760  NOTUM; palmitoleoyl-protein carboxylesterase NOTUM [KO:K19882] [EC:3.1.1.98]
109270441  WIF1; wnt inhibitory factor 1 [KO:K01691]
109258243  SOST; sclerostin [KO:K16834]
109247753  DKK2; dickkopf-related protein 2 [KO:K02165]
109255421  DKK1; LOW QUALITY PROTEIN: dickkopf-related protein 1 [KO:K02165]
109262262  DKK4; dickkopf-related protein 4 [KO:K02165]
109255141  SERPINF1; pigment epithelium-derived factor [KO:K19614]
109262279  SFRP1; secreted frizzled-related protein 1 isoform X1 [KO:K02166]
109262506  SFRP2; secreted frizzled-related protein 2 [KO:K02176]
109274090  FRZB; secreted frizzled-related protein 3 isoform X1 [KO:K25481]
109268047  SFRP4; secreted frizzled-related protein 4 isoform X1 [KO:K02185]
109272734  SFRP5; secreted frizzled-related protein 5 [KO:K02222]
109255507  RSPO1; R-spondin-1 [KO:K19471]
109277937  RSPO2; R-spondin-2 [KO:K23097]
109248514  RSPO3; R-spondin-3 isoform X1 [KO:K23098]
109272631  RSPO4; R-spondin-4 [KO:K23099]
109271278  LGR4; leucine-rich repeat-containing G-protein coupled receptor 4 isoform X1 [KO:K04309]
109270514  LGR5; leucine-rich repeat-containing G-protein coupled receptor 5 isoform X1 [KO:K04308]
109256363  LGR6; leucine-rich repeat-containing G-protein coupled receptor 6 [KO:K08399]
109247201  RNF43; E3 ubiquitin-protein ligase RNF43 isoform X1 [KO:K15694] [EC:2.3.2.27]
109253549  ZNRF3; E3 ubiquitin-protein ligase ZNRF3 isoform X1 [KO:K16273] [EC:2.3.2.27]
109259199  FZD7; frizzled-7 [KO:K02432]
109263669  FZD1; frizzled-1 [KO:K02432]
109258237  FZD2; frizzled-2 [KO:K02235]
109262362  FZD3; frizzled-3 isoform X1 [KO:K02329]
109267311  FZD4; frizzled-4 isoform X1 [KO:K02354]
109276176  frizzled-8-like [KO:K02375]
109265155  FZD5; frizzled-5 [KO:K02375]
109276288  FZD8; frizzled-8 [KO:K02375]
109277964  FZD6; frizzled-6 [KO:K02376]
109257591  FZD10; frizzled-10 [KO:K02842]
109250592  FZD9; frizzled-9 [KO:K02842]
109268615  LRP6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
109246877  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
109276344  BAMBI; BMP and activin membrane-bound inhibitor homolog [KO:K10162]
109248651  APCDD1; protein APCDD1 [KO:K25812]
109253470  APCDD1L; protein APCDD1-like [KO:K25812]
109265563  casein kinase I isoform X1 [KO:K08960] [EC:2.7.11.1]
109274458  CCDC88C; protein Daple isoform X1 [KO:K25811]
109273921  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
109275214  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
109245979  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
109272709  FRAT1; proto-oncogene FRAT1 [KO:K03069]
109272710  FRAT2; GSK-3-binding protein FRAT2 isoform X1 [KO:K03096]
109261937  GSK-3-binding protein FRAT2-like [KO:K03096]
109272621  CSNK2A1; casein kinase II subunit alpha [KO:K03097] [EC:2.7.11.1]
109270846  CSNK2A2; casein kinase II subunit alpha' isoform X1 [KO:K03097] [EC:2.7.11.1]
109260518  CSNK2B; casein kinase II subunit beta [KO:K03115]
109260201  NKD2; protein naked cuticle homolog 2 [KO:K03213]
109270951  NKD1; protein naked cuticle homolog 1 isoform X1 [KO:K03213]
109247603  CXXC4; CXXC-type zinc finger protein 4 [KO:K03344]
109275253  SENP2; sentrin-specific protease 2 isoform X1 [KO:K03345] [EC:3.4.22.68]
109266441  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
109248805  CTNNB1; catenin beta-1 [KO:K02105]
109259643  AXIN1; axin-1 isoform X1 [KO:K02157]
109277160  AXIN2; axin-2 [KO:K04385]
109257701  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
109267599  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
109275937  CSNK1A1; casein kinase I isoform X1 [KO:K08957] [EC:2.7.11.1]
109250863  TCF7; transcription factor 7 isoform X1 [KO:K02620]
109263707  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
109272915  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
109247814  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
109272781  LZTS2; leucine zipper putative tumor suppressor 2 isoform X1 [KO:K26471]
109274083  CTNNBIP1; beta-catenin-interacting protein 1 [KO:K04493]
109265573  CBY1; protein chibby homolog 1 isoform X1 [KO:K23402]
109255748  CHD8; chromodomain-helicase-DNA-binding protein 8 isoform X1 [KO:K04494] [EC:5.6.2.-]
109267594  MCC; colorectal mutant cancer protein isoform X1 [KO:K26734]
109277341  CCAR2; cell cycle and apoptosis regulator protein 2 isoform X1 [KO:K25816]
109264323  SIRT1; NAD-dependent protein deacetylase sirtuin-1 isoform X1 [KO:K11411] [EC:2.3.1.286]
109258438  transcription factor SOX-17 [KO:K04495]
109252294  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
109259305  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
109270661  transducin-like enhancer protein 2 isoform X1 [KO:K04497]
109262759  TLE3; transducin-like enhancer protein 3 isoform X1 [KO:K04497]
109275356  TLE4; transducin-like enhancer protein 4 isoform X1 [KO:K04497]
109258877  transducin-like enhancer protein 1 isoform X1 [KO:K04497]
109256003  TLE6; transducin-like enhancer protein 6 isoform X1 [KO:K04497]
109267794  CTNND2; catenin delta-2 [KO:K23491]
109278438  CREBBP; LOW QUALITY PROTEIN: CREB-binding protein [KO:K04498] [EC:2.3.1.48]
109265617  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
109256064  RUVBL1; ruvB-like 1 isoform X1 [KO:K04499] [EC:5.6.2.4]
109275709  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
109262802  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
109263420  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
109251873  NLK; serine/threonine-protein kinase NLK isoform X1 [KO:K04468] [EC:2.7.11.24]
109273136  MYC; myc proto-oncogene protein [KO:K04377]
109266785  JUN; transcription factor AP-1 [KO:K04448]
109246767  FOSL1; fos-related antigen 1 isoform X1 [KO:K04502]
109246902  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
109276198  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
109271613  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
109273106  WISP1; WNT1-inducible-signaling pathway protein 1 [KO:K22471]
109271495  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
109257534  MMP7; matrilysin [KO:K01397] [EC:3.4.24.23]
109253789  PSEN1; presenilin-1 isoform X1 [KO:K04505] [EC:3.4.23.-]
109246175  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
109253991  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
109245932  TP53; cellular tumor antigen p53 [KO:K04451]
109248333  E3 ubiquitin-protein ligase SIAH1-like [KO:K04506] [EC:2.3.2.27]
109270972  SIAH1; E3 ubiquitin-protein ligase SIAH1 isoform X1 [KO:K04506] [EC:2.3.2.27]
109252918  CACYBP; calcyclin-binding protein [KO:K04507]
109271783  S-phase kinase-associated protein 1 [KO:K03094]
109250862  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
109248273  TBL1X; F-box-like/WD repeat-containing protein TBL1X isoform X1 [KO:K04508]
109275152  TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1 isoform X1 [KO:K04508]
109267495  FBXW11; F-box/WD repeat-containing protein 11 isoform X1 [KO:K03362]
109272793  BTRC; F-box/WD repeat-containing protein 1A isoform X1 [KO:K03362]
109269217  CUL1; cullin-1 isoform X1 [KO:K03347]
109265611  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
109253733  GPC4; glypican-4 [KO:K08110]
109266737  ROR1; inactive tyrosine-protein kinase transmembrane receptor ROR1 [KO:K05122] [EC:2.7.10.1]
109275513  ROR2; tyrosine-protein kinase transmembrane receptor ROR2 isoform X1 [KO:K05123] [EC:2.7.10.1]
109259376  RYK; tyrosine-protein kinase RYK isoform X1 [KO:K05128] [EC:2.7.10.1]
109272116  VANGL1; vang-like protein 1 [KO:K04510]
109257206  VANGL2; vang-like protein 2 [KO:K04510]
109271608  PRICKLE4; prickle-like protein 4 isoform X1 [KO:K04511]
109279060  PRICKLE2; prickle-like protein 2 isoform X1 [KO:K04511]
109268845  PRICKLE1; prickle-like protein 1 [KO:K04511]
109248094  PRICKLE3; prickle-like protein 3 isoform X1 [KO:K04511]
109270071  INVS; inversin isoform X1 [KO:K19626]
109268400  DAAM1; disheveled-associated activator of morphogenesis 1 isoform X1 [KO:K04512]
109271577  DAAM2; disheveled-associated activator of morphogenesis 2 isoform X1 [KO:K04512]
109247805  RHOA; transforming protein RhoA [KO:K04513]
109268495  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
109251192  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
109265228  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
109277132  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
109278973  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
109276314  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
109264550  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
109246661  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
109274721  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
109274722  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
109263166  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
109264424  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
109275954  calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
109248360  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
109267916  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
109247332  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
109277349  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
109262013  PPP3R1; calcineurin subunit B type 1 isoform X1 [KO:K06268]
109270050  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
109277056  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
109255537  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
109259277  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
109251747  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
109272263  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
109270732  NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333]
109254966  NFATC4; nuclear factor of activated T-cells, cytoplasmic 4 [KO:K17334]
Compound
C00076  Calcium cation
Reference
  Authors
Hatsell S, Rowlands T, Hiremath M, Cowin P.
  Title
Beta-catenin and Tcfs in mammary development and cancer.
  Journal
J Mammary Gland Biol Neoplasia 8:145-58 (2003)
DOI:10.1023/A:1025944723047
Reference
  Authors
Yang Y.
  Title
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.
  Journal
Birth Defects Res Part C Embryo Today 69:305-17 (2003)
DOI:10.1002/bdrc.10026
Reference
  Authors
Kalderon D.
  Title
Similarities between the Hedgehog and Wnt signaling pathways.
  Journal
Trends Cell Biol 12:523-31 (2002)
DOI:10.1016/S0962-8924(02)02388-7
Reference
  Authors
Nusse R.
  Title
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
  Journal
Development 130:5297-305 (2003)
DOI:10.1242/dev.00821
Reference
  Authors
Jope RS, Johnson GV.
  Title
The glamour and gloom of glycogen synthase kinase-3.
  Journal
Trends Biochem Sci 29:95-102 (2004)
DOI:10.1016/j.tibs.2003.12.004
Reference
  Authors
Veeman MT, Axelrod JD, Moon RT.
  Title
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
  Journal
Dev Cell 5:367-77 (2003)
DOI:10.1016/S1534-5807(03)00266-1
Reference
  Authors
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.
  Title
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.
  Journal
Nat Cell Biol 3:628-36 (2001)
DOI:10.1038/35083016
Reference
  Authors
Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E
  Title
The way Wnt works: Components and mechanism.
  Journal
Growth Factors 31:1-31 (2013)
DOI:10.3109/08977194.2012.752737
Reference
  Authors
Carethers JM
  Title
Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.
  Journal
Gastroenterology 137:33-6 (2009)
DOI:10.1053/j.gastro.2009.05.011
Reference
  Authors
Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG
  Title
The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.
  Journal
J Biol Chem 283:33053-8 (2008)
DOI:10.1074/jbc.M804039200
Reference
  Authors
Niehrs C
  Title
The complex world of WNT receptor signalling.
  Journal
Nat Rev Mol Cell Biol 13:767-79 (2012)
DOI:10.1038/nrm3470
Reference
  Authors
Abou Ziki MD, Mani A
  Title
Wnt signaling, a novel pathway regulating blood pressure? State of the art review.
  Journal
Atherosclerosis 262:171-178 (2017)
DOI:10.1016/j.atherosclerosis.2017.05.001
Reference
  Authors
He Y, Ki H, Kim H, Kim K
  Title
delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.
  Journal
Cell Biol Int 39:954-61 (2015)
DOI:10.1002/cbin.10465
Reference
  Authors
Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M
  Title
The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.
  Journal
Biochem Biophys Res Commun 532:406-413 (2020)
DOI:10.1016/j.bbrc.2020.08.066
Reference
  Authors
Yiew NKH, Chatterjee TK, Tang YL, Pellenberg R, Stansfield BK, Bagi Z, Fulton DJ, Stepp DW, Chen W, Patel V, Kamath VM, Litwin SE, Hui DY, Rudich SM, Kim HW, Weintraub NL
  Title
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.
  Journal
J Biol Chem 292:6312-6324 (2017)
DOI:10.1074/jbc.M116.758078
Related
pathway
ppad04010  MAPK signaling pathway
ppad04110  Cell cycle
ppad04115  p53 signaling pathway
ppad04120  Ubiquitin mediated proteolysis
ppad04350  TGF-beta signaling pathway
ppad04510  Focal adhesion
ppad04520  Adherens junction
ppad05010  Alzheimer disease
KO pathway
ko04310   
LinkDB

DBGET integrated database retrieval system